| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net cash (used in) provided by financing activities | -89,479 | -79,088 |
| Net (decrease) increase in cash and cash equivalents | -13,247 | -78,782 |
| Cash and cash equivalents at beginning of period | 123,080 | - |
| Cash and cash equivalents at end of period | 109,833 | - |
ANAPTYSBIO, INC (ANAB)
ANAPTYSBIO, INC (ANAB)